Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
UBS
Fish and Richardson
Accenture
QuintilesIMS
Queensland Health
Fuji
Cantor Fitzgerald
Colorcon

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,382,573

« Back to Dashboard

Summary for Patent: 5,382,573
Title: Hormone preparation and method
Abstract:This invention is concerned with a contraceptive formulation and a method of contraception which employs a combination of estrogen and progestin and wherein a short period of relatively dominant estrogenic activity alternates with a short period of relatively dominant progestagenic activity. The invention also concerns a hormonal replacement formulation and method for use in menopausal or castrate women which employs a similar combination of estrogen and progestin.
Inventor(s): Casper; Robert F. (Toronto, CA)
Assignee: Jencap Research Ltd. (Toronto, CA)
Application Number:08/143,055
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,382,573
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 5,382,573

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,382,573

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Canada547743Sep 24, 1987
Canada547744Sep 24, 1987

International Family Members for US Patent 5,382,573

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 102484 ➤ Try a Free Trial
Austria 209919 ➤ Try a Free Trial
Australia 2276088 ➤ Try a Free Trial
Australia 3044892 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
McKinsey
Express Scripts
Chinese Patent Office
Fuji
Covington
Medtronic
Citi
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.